查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1957406

2026年全球医疗设备临床试验市场报告

Medical Device Clinical Trials Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，医疗设备临床试验市场经历了显着成长。预计该市场规模将从2025年的180.7亿美元成长到2026年的193.6亿美元，复合年增长率（CAGR）为7.2%。过去几年的成长主要归功于医疗设备创新技术的进步、监管核准要求的日益严格、对病人安全检验需求的不断增长、医院临床研究的扩展以及对临床证据产生投入的增加。

预计未来几年医疗设备临床试验市场将维持强劲成长，2030年市场规模将达到253.5亿美元，复合年增长率（CAGR）为7.0%。预测期内的成长要素包括穿戴式和互联医疗设备的普及、监管机构对设备性能的监管力度加大、数位化试验平台的扩展、远端患者监护在试验中的应用日益广泛以及临床研究的全球化。预测期内的关键趋势包括分散式临床试验的日益普及、真实世界数据在器械试验中的应用日益广泛、对核准后和长期安全性研究的日益重视、适应性试验和混合试验设计的扩展以及对符合监管要求的试验管理需求的增加。

未来几年，慢性病盛行率的不断上升预计将推动医疗设备临床试验市场的成长。慢性病是指那些在较长时间内逐渐发展且需要持续医疗管理的健康状况。这种增长与久坐的生活方式密切相关，例如长时间坐着、因使用电子萤幕导致的卡路里消耗减少以及心血管功能下降，从而导致肥胖、糖尿病和高血压等疾病。慢性病负担的加重使得临床试验的需求日益增长，这些试验旨在开发和检验用于有效诊断、治疗和疾病管理的创新医疗设备。例如，根据美国公共卫生研究机构健康指标与评估研究所 (IHME) 于 2023 年 6 月发布的报告，全球有超过 5 亿人患有糖尿病，预计到 2050 年，这一数字将翻一番以上，达到 13 亿人。慢性病盛行率的不断上升正在推动医疗设备临床试验市场的扩张。

医疗设备临床试验市场的主要企业正致力于开发人工智慧驱动的医疗设备软体，以优化临床试验通讯协定、简化资源分配，并同时提高试验效率和降低成本。人工智慧驱动的医疗设备软体利用人工智慧技术，包括机器学习和深度学习演算法，来支援或自动化医疗操作。例如，总部位于瑞士的製药公司Risklick于2025年1月发布了名为「Protocol AI」的人工智慧软体，旨在加速和优化医疗设备临床试验。 Protocol AI利用自然语言处理（NLP）和机器学习（ML）技术分析临床数据、学术论文和监管文件，可在数分钟内自动产生临床试验通讯协定。这项创新技术大幅缩短了通讯协定开发的时间和成本（传统方案开发通常需要约六个月），并已被证明可将製药业的文件编制时间缩短高达50%。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球医疗设备临床试验市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施、互联生态系统
    • 生物技术、基因体学、精准医疗
  • 主要趋势
    • 分散式临床试验的采用率不断提高
    • 扩大真实世界数据在医疗设备测试的应用
    • 人们越来越关注核准后和长期安全测试
    • 扩展自适应和混合测试设计
    • 对符合监管要求的测试管理的需求日益增长

第五章 终端用户产业市场分析

  • 医疗设备製造商
  • 合约研究机构
  • 医院
  • 学术研究机构
  • 监理和合规机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球医疗设备临床试验市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球医疗设备临床试验市场规模、比较及成长率分析
  • 全球医疗设备临床试验市场表现：规模与成长，2020-2025年
  • 全球医疗设备临床试验市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 按研究类型
  • 可行性研究和试点研究、关键性研究、FDA上市前核准（PMA）申请和上市后监测。
  • 指示
  • 循环系统器材、神经器材、整形外科器材、诊断影像设备、麻醉和呼吸器材等适应症
  • 透过研究设计
  • 介入研究、观察性研究、扩大准入
  • 按类型细分：可行性研究与试点研究
  • 首次人体试验、医疗设备安全评估、可行性研究、原型测试。
  • 按类型细分：关键测试
  • 比较疗效研究、随机对照试验（RCT）、非劣效性试验、优效性试验
  • 按类型细分：FDA PMA（上市前核准）申请
  • 临床资料提交、医疗设备风险分析、疗效证据研究。
  • 按类型细分：核准后调查
  • 长期安全性监测、真实世界证据蒐集、註册研究、比较结果研究

第十章 区域与国别分析

  • 全球医疗设备临床试验市场：按地区划分，实际结果和预测，2020-2025年、2025-2030年、2035年
  • 全球医疗设备临床试验市场：按国家/地区划分，实际结果和预测，2020-2025年、2025-2030年、2035年

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 医疗设备临床试验市场：竞争格局及市场占有率（2024年）
  • 医疗设备临床试验市场：公司评估矩阵
  • 医疗设备临床试验市场：公司概况
    • Abbott Laboratories
    • Siemens Healthineers
    • Stryker Corporation
    • Philips Healthcare
    • Baxter International

第37章 其他大型企业和创新企业

  • Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年医疗设备临床试验市场：提供新机会的国家
  • 2030年医疗设备临床试验市场：新兴细分市场机会
  • 2030年医疗设备临床试验市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH5MMDCT01_G26Q1

Medical device clinical trials are research studies designed to evaluate the safety and effectiveness of medical devices in humans. The process includes phases such as feasibility, pivotal, and post-approval studies, which are necessary for regulatory approval. These trials generate critical data to support device market authorization and ongoing safety monitoring.

The main study types in medical device clinical trials include feasibility and pilot studies, pivotal studies, FDA premarket approval (PMA) applications, and post-approval studies. Feasibility and pilot studies are early-phase trials conducted with a small group of participants to assess the practicality, safety, and potential challenges of a new device before progressing to larger trials. These studies are conducted across various indications, including cardiovascular, neurology, orthopedic, diagnostic imaging, anesthesia and respiratory devices, and others. Study designs typically include interventional, observational, and expanded access approaches.

Tariffs have influenced the medical device clinical trials market by increasing costs for imported trial devices, monitoring equipment, and data collection technologies. These impacts are most evident in cardiovascular, orthopedic, and diagnostic device trials, particularly across North America, Europe, and Asia-Pacific regions. Higher tariffs have raised overall trial execution costs and delayed multinational study timelines. However, tariffs have also encouraged local trial execution, regional manufacturing of investigational devices, and increased domestic clinical research capacity.

The medical device clinical trials market research report is one of a series of new reports from The Business Research Company that provides medical device clinical trials market statistics, including medical device clinical trials industry global market size, regional shares, competitors with a medical device clinical trials market share, detailed medical device clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the medical device clinical trials industry. This medical device clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical device clinical trials market size has grown strongly in recent years. It will grow from $18.07 billion in 2025 to $19.36 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growth in medical device innovation, stringent regulatory approval requirements, rising demand for patient safety validation, expansion of hospital-based clinical research, increasing investment in clinical evidence generation.

The medical device clinical trials market size is expected to see strong growth in the next few years. It will grow to $25.35 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to growth in wearable and connected medical devices, increasing regulatory scrutiny on device performance, expansion of digital trial platforms, rising adoption of remote patient monitoring in trials, increasing globalization of clinical studies. Major trends in the forecast period include increasing adoption of decentralized clinical trials, growing use of real-world evidence in device trials, rising focus on post-approval and long-term safety studies, expansion of adaptive and hybrid trial designs, increasing demand for regulatory-compliant trial management.

The increasing prevalence of chronic diseases is expected to drive the growth of the medical device clinical trials market in the coming years. Chronic diseases are long-term health conditions that progress gradually and require ongoing medical management. Their rise is linked to sedentary lifestyles, where extended periods of sitting or screen use reduce calorie expenditure and weaken cardiovascular health, contributing to conditions such as obesity, diabetes, and hypertension. The growing burden of chronic diseases fuels the need for medical device clinical trials to develop and validate innovative devices for effective diagnosis, treatment, and disease management. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes, a number projected to more than double to 1.3 billion by 2050. Consequently, the rising prevalence of chronic diseases is driving the expansion of the medical device clinical trials market.

Major companies in the medical device clinical trials market are focusing on developing AI-powered medical device software to optimize clinical trial protocols, streamline resource allocation, and enhance trial efficiency while reducing costs. AI-powered medical device software uses artificial intelligence, including machine learning and deep learning algorithms, to support or automate healthcare tasks. For example, in January 2025, Risklick, a Switzerland-based pharmaceutical company, launched Protocol AI, an AI-based software designed to accelerate and optimize clinical trials for medical devices. Protocol AI employs Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, automatically generating clinical trial protocols in minutes. This innovation significantly reduces the time and cost of protocol development, which traditionally takes around six months, and has demonstrated up to a 50% reduction in document preparation time for medicinal products.

In January 2024, eMed, a US-based health services company, acquired Science 37 for $38 million. The acquisition enhances eMed's clinical research capabilities by integrating telehealth and diagnostic services with decentralized trial technology, improving patient enrollment and expanding access to underrepresented populations. Science 37 is a US-based research company specializing in decentralized clinical trials, including those for medical devices.

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical device clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical device clinical trials market includes revenues earned by entities by providing services such as clinical trial design and management, regulatory consulting, site selection and monitoring, patient recruitment, data management, and statistical analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical device clinical trials market also includes sales of diagnostic devices, therapeutic devices, surgical instruments, monitoring equipment, implantable devices, wearable health technologies, and medical imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Device Clinical Trials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses medical device clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical device clinical trials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical device clinical trials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Study Type: Feasibility And Pilot Study; Pivotal Study; FDA Premarket Approval (PMA) Application; Post-Approval Study
  • 2) By Indication: Cardiovascular Devices; Neurology Devices; Orthopedic Devices; Diagnostic Imaging; Anesthesia And Respiratory Devices; Other Indications
  • 3) By Study Design: Interventional; Observational; Expanded Access
  • Subsegments:
  • 1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials; Device Safety Assessment; Procedural Feasibility Studies; Prototype Testing
  • 2) By Pivotal Study: Comparative Effectiveness Studies; Randomized Controlled Trials (RCTs); Non-Inferiority Trials; Superiority Trials
  • 3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission; Device Risk Analysis; Effectiveness Evidence Studies
  • 4) By Post-Approval Study: Long-Term Safety Monitoring; Real-World Evidence Collection; Registry Studies; Comparative Outcome Studies
  • Companies Mentioned: Abbott Laboratories; Siemens Healthineers; Stryker Corporation; Philips Healthcare; Baxter International; Roche Diagnostics; ICON; Intuitive Surgical; Edwards Lifesciences; Fortrea; Medidata; NAMSA; Veranex; TFS HealthScience; Avania; Parexel; Meditrial; Syneos Health; Qserve CRO; Clinius Ltd; Eclevar Medtech; 1med Sa; ISS AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Medical Device Clinical Trials Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Medical Device Clinical Trials Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Medical Device Clinical Trials Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Medical Device Clinical Trials Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Biotechnology, Genomics & Precision Medicine
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Decentralized Clinical Trials
    • 4.2.2 Growing Use Of Real-World Evidence In Device Trials
    • 4.2.3 Rising Focus On Post-Approval And Long-Term Safety Studies
    • 4.2.4 Expansion Of Adaptive And Hybrid Trial Designs
    • 4.2.5 Increasing Demand For Regulatory-Compliant Trial Management

5. Medical Device Clinical Trials Market Analysis Of End Use Industries

  • 5.1 Medical Device Manufacturers
  • 5.2 Contract Research Organizations
  • 5.3 Hospitals
  • 5.4 Academic Research Institutes
  • 5.5 Regulatory And Compliance Organizations

6. Medical Device Clinical Trials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Medical Device Clinical Trials Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Medical Device Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Medical Device Clinical Trials Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Medical Device Clinical Trials Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Medical Device Clinical Trials Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Medical Device Clinical Trials Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Medical Device Clinical Trials Market Segmentation

  • 9.1. Global Medical Device Clinical Trials Market, Segmentation By Study Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study
  • 9.2. Global Medical Device Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications
  • 9.3. Global Medical Device Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Interventional, Observational, Expanded Access
  • 9.4. Global Medical Device Clinical Trials Market, Sub-Segmentation Of Feasibility And Pilot Study, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing
  • 9.5. Global Medical Device Clinical Trials Market, Sub-Segmentation Of Pivotal Study, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials
  • 9.6. Global Medical Device Clinical Trials Market, Sub-Segmentation Of FDA PMA (Pre-Market Approval) Application, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies
  • 9.7. Global Medical Device Clinical Trials Market, Sub-Segmentation Of Post-Approval Study, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

10. Medical Device Clinical Trials Market Regional And Country Analysis

  • 10.1. Global Medical Device Clinical Trials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Medical Device Clinical Trials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Medical Device Clinical Trials Market

  • 11.1. Asia-Pacific Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Medical Device Clinical Trials Market

  • 12.1. China Medical Device Clinical Trials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Medical Device Clinical Trials Market

  • 13.1. India Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Medical Device Clinical Trials Market

  • 14.1. Japan Medical Device Clinical Trials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Medical Device Clinical Trials Market

  • 15.1. Australia Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Medical Device Clinical Trials Market

  • 16.1. Indonesia Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Medical Device Clinical Trials Market

  • 17.1. South Korea Medical Device Clinical Trials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Medical Device Clinical Trials Market

  • 18.1. Taiwan Medical Device Clinical Trials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Medical Device Clinical Trials Market

  • 19.1. South East Asia Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Medical Device Clinical Trials Market

  • 20.1. Western Europe Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Medical Device Clinical Trials Market

  • 21.1. UK Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Medical Device Clinical Trials Market

  • 22.1. Germany Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Medical Device Clinical Trials Market

  • 23.1. France Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Medical Device Clinical Trials Market

  • 24.1. Italy Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Medical Device Clinical Trials Market

  • 25.1. Spain Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Medical Device Clinical Trials Market

  • 26.1. Eastern Europe Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Medical Device Clinical Trials Market

  • 27.1. Russia Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Medical Device Clinical Trials Market

  • 28.1. North America Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Medical Device Clinical Trials Market

  • 29.1. USA Medical Device Clinical Trials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Medical Device Clinical Trials Market

  • 30.1. Canada Medical Device Clinical Trials Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Medical Device Clinical Trials Market

  • 31.1. South America Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Medical Device Clinical Trials Market

  • 32.1. Brazil Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Medical Device Clinical Trials Market

  • 33.1. Middle East Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Medical Device Clinical Trials Market

  • 34.1. Africa Medical Device Clinical Trials Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Medical Device Clinical Trials Market, Segmentation By Study Type, Segmentation By Indication, Segmentation By Study Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Medical Device Clinical Trials Market Regulatory and Investment Landscape

36. Medical Device Clinical Trials Market Competitive Landscape And Company Profiles

  • 36.1. Medical Device Clinical Trials Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Medical Device Clinical Trials Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Medical Device Clinical Trials Market Company Profiles
    • 36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Baxter International Overview, Products and Services, Strategy and Financial Analysis

37. Medical Device Clinical Trials Market Other Major And Innovative Companies

  • Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd

38. Global Medical Device Clinical Trials Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Medical Device Clinical Trials Market

40. Medical Device Clinical Trials Market High Potential Countries, Segments and Strategies

  • 40.1 Medical Device Clinical Trials Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Medical Device Clinical Trials Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Medical Device Clinical Trials Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer